Dose-Exposure-Response in Type 1 Diabetes Mellitus
NCT00368394
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus, Type I
Interventions
DRUG:
Insulin glulisine
Sponsor
Sanofi